Quick Answer
Forte Biosciences, Inc. reported Net Income of -$69.38 million for fiscal year 2025.
Forte Biosciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$69.38M | -95.5% |
| 2024 | -$35.48M | -12.7% |
| 2023 | -$31.48M | -126.8% |
| 2022 | -$13.88M | +36.1% |
| 2021 | -$21.71M | +53.3% |
| 2020 | -$46.49M | -1042.5% |
| 2019 | -$4.07M | +91.7% |
| 2018 | -$48.95M | -25.8% |
| 2017 | -$38.93M | -16.3% |
| 2016 | -$33.48M | -45.2% |
| 2015 | -$23.06M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$17.68M | -110.7% | -57.2% |
| June 30, 2025 | -$11.25M | +10.1% | +28.1% |
| March 31, 2025 | -$15.66M | -111.0% | -86.6% |
| September 30, 2024 | -$8.39M | +15.7% | +32.9% |
| June 30, 2024 | -$12.51M | -40.6% | -68.6% |
| March 31, 2024 | -$7.42M | -9.9% | +25.5% |
| September 30, 2023 | -$9.96M | -192.8% | -11.9% |
| June 30, 2023 | -$8.90M | -193.1% | -31.7% |
- Forte Biosciences, Inc. showed a decrease of -95.5% in Net Income compared to the prior fiscal year.
- Over the 2015–2025 period, Forte Biosciences, Inc.’s net income has declined by 200.9% (from -$23.06 million to -$69.38 million).
- The most recent figure is from Forte Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: